Communications of the ACM
ACM News
First Crispr Clinical Trial Gets Green Light from S Panel
Human T cells (blue) will soon be modified using the CRISPR technique in a clinical trial to attack cancer cells (pink).
Credit: Steve Gschmeissner/SPL
CRISPR, the genome-editing technology that has taken biomedical science by storm, is finally nearing human trials.
From Nature
View Full Article
No entries found